3
Announcements
Trials
Browse
Landscape
Status
No longer available
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
31
Expanded_access
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Conditions
Stomach Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Interventions
gallium 68 PSMA-11
4
Magnetic Resonance Spectroscopy
4
carbon-11 acetate
2
Abiraterone Acetate
2
2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid
2
zenocutuzumab
1
tempol
1
talazoparib
1
radium Ra 223 dichloride
1
pegilodecakin
1
motexafin gadolinium
1
bicalutamide
1
balstilimab
1
apalutamide
1
TEMPOL-H
1
Suspensions
1
Standard of Care
1
Sodium Acetate
1
Proton Pump Inhibitors
1
Prednisone
1
Prednisolone
1
Powders
1
Positron-Emission Tomography
1
Positron Emission Tomography Computed Tomography
1
Paclitaxel
1
N,N'-bis(2-hydroxy-5-(ethylene-beta-carboxy)benzyl)ethylenediamine N,N'-diacetic acid
1
MLN 8237
1
Hydrocortisone
1
Gadolinium
1
Androgen Antagonists
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Expanded_access
×
Prostatic Neoplasms
×
Paclitaxel
×
Clear all
NCT03756311
2026-01-23
Expanded Access to NanoPac
NanOlogy, LLC
No longer available